JARID2 and hepatocellular carcinoma: For example, JARID2 is overexpressed in hepatocellular carcinoma (HCC) tissues [7], where its upregulation promotes EMT by inhibiting the phosphatase and tension homolog (PTEN)-induced AKT hyperactivation, resulting in enhanced invasion of HCC cells.